Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Net Margin (2016 - 2025)

Bio Key International (BKYI) has disclosed Net Margin for 16 consecutive years, with 62.26% as the latest value for Q3 2025.

  • Quarterly Net Margin fell 2781.0% to 62.26% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 67.34% through Sep 2025, up 519.0% year-over-year, with the annual reading at 62.06% for FY2024, 4783.0% up from the prior year.
  • Net Margin hit 62.26% in Q3 2025 for Bio Key International, up from 68.8% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 23.39% in Q1 2024 to a low of 386.09% in Q4 2022.
  • Historically, Net Margin has averaged 109.86% across 5 years, with a median of 88.28% in 2022.
  • Biggest five-year swings in Net Margin: soared 62153bps in 2021 and later crashed -16906bps in 2022.
  • Year by year, Net Margin stood at 217.02% in 2021, then plummeted by -78bps to 386.09% in 2022, then surged by 66bps to 130.01% in 2023, then increased by 27bps to 94.68% in 2024, then surged by 34bps to 62.26% in 2025.
  • Business Quant data shows Net Margin for BKYI at 62.26% in Q3 2025, 68.8% in Q2 2025, and 45.83% in Q1 2025.